User profiles for K. Fragiadaki
Katerina FragkiadakiAssociate Professor, Carnegie Mellon University Verified email at cs.cmu.edu Cited by 5182 |
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients
A Arida, K Fragiadaki, E Giavri, PP Sfikakis - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVE:: Off-label use of anti-tumor necrosis factor (TNF) agents for Behçet's disease (BD)
is increasing. We evaluated published data on their efficacy and safety for patients with …
is increasing. We evaluated published data on their efficacy and safety for patients with …
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: an open …
…, S Lionaki, V Vigklis, KG Fragiadaki… - … : Official Journal of …, 2005 - Wiley Online Library
Objective Autoreactive B cells play a key role in tissue injury in systemic autoimmune
disease, and therefore a treatment resulting in B cell depletion could have benefit. This open‐label …
disease, and therefore a treatment resulting in B cell depletion could have benefit. This open‐label …
A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis
…, E Zampeli, K Fragiadaki, K Stamatelopoulos… - Atherosclerosis, 2011 - Elsevier
Interleukin (IL)-6 is a pleiotropic proinflammatory cytokine involved in the pathogenesis of
both atherosclerosis and rheumatoid arthritis. The role of the IL-6/IL-6 receptor pathway in the …
both atherosclerosis and rheumatoid arthritis. The role of the IL-6/IL-6 receptor pathway in the …
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis
PP Sfikakis, VL Souliotis, KG Fragiadaki… - Clinical …, 2007 - Elsevier
B cell depletion may affect T cell activation and costimulation status in rituximab-treated
patients with SLE. We examined whether rituximab administration in patients with active lupus …
patients with SLE. We examined whether rituximab administration in patients with active lupus …
Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort
…, VK Bournia, G Konstantonis, K Fragiadaki… - Autoimmunity …, 2018 - Elsevier
Objectives To determine predictors of morbidity and mortality in systemic sclerosis (SSc) in
a long-term follow-up of an inception cohort of early SSc patients. Methods We evaluated …
a long-term follow-up of an inception cohort of early SSc patients. Methods We evaluated …
A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet's disease: a comparative 4-week study
…, E Delicha, S Masselos, K Fragiadaki… - …, 2011 - academic.oup.com
Objective. To compare a single infusion of the anti-TNF antibody infliximab vs CSs for acute
panuveitis attacks in Behçet’s disease (BD). Methods. A prospective, observational study of …
panuveitis attacks in Behçet’s disease (BD). Methods. A prospective, observational study of …
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases
…, S Panopoulos, K Fragiadaki… - Annals of the …, 2022 - ard.bmj.com
Objective Τo report outcomes of breakthrough COVID-19 in comparison with COVID-19 in
unvaccinated patients with systemic rheumatic diseases (SRDs). Methods Patients with SRD …
unvaccinated patients with systemic rheumatic diseases (SRDs). Methods Patients with SRD …
Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic
…, A Arida, VK Bournia, K Fragiadaki… - Annals of the …, 2021 - ard.bmj.com
We read with great interest the preliminary German Society of Rheumatology recommendations
for the management of patients with autoimmune inflammatory rheumatic diseases (…
for the management of patients with autoimmune inflammatory rheumatic diseases (…
[PDF][PDF] Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis
E Terpos, K Fragiadaki, M Konsta… - Clinical and …, 2011 - clinexprheumatol.org
Objective A critical role of interleukin-6 (IL-6) in bone homeostasis has been suggested in
experimental studies. We examined whether inhibition of IL-6 receptor in patients with …
experimental studies. We examined whether inhibition of IL-6 receptor in patients with …
Recurrent network models for human dynamics
K Fragkiadaki, S Levine, P Felsen… - Proceedings of the IEEE …, 2015 - cv-foundation.org
… We represent K body joint locations as a set of KN ×N heat maps over the person’s
bounding box, that represent likelihood for each joint to appear in each of the N2 grid locations, …
bounding box, that represent likelihood for each joint to appear in each of the N2 grid locations, …